Emerging Medication in Australia: A Promising Breakthrough for Weight Loss ?
Australia is eagerly anticipating the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor agonist , representing a potential advance in weight loss . Early research findings have demonstrated impressive results, showing greater effectiveness than existing treatments like semaglutide.